Elsayed Mustafa M A, Alfagih Iman M, Brockbank Katrina, Alheibshy Fawaz, Aodah Alhassan H, Ali Raisuddin, Almansour Khaled, Shalash Ahmed O
Department of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il, Saudi Arabia.
Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
Int J Pharm X. 2024 May 1;7:100251. doi: 10.1016/j.ijpx.2024.100251. eCollection 2024 Jun.
The contributions of fine excipient materials to drug dispersibility from carrier-based dry powder inhalation (DPI) formulations are well recognized, although they are not completely understood. To improve the understanding of these contributions, we investigated the influences of the particle size of the fine excipient materials on characteristics of carrier-based DPI formulations. We studied two particle size grades of silica microspheres, with volume median diameters of 3.31 μm and 8.14 μm, as fine excipient materials. Inhalation formulations, each composed of a lactose carrier material, one of the fine excipient materials (2.5% or 15.0% /), and a drug (fluticasone propionate) material (1.5% /) were prepared. The physical microstructure, the rheological properties, the aerosolization pattern, and the aerodynamic performance of the formulations were studied. At low concentration, the large silica microspheres had a more beneficial influence on the drug dispersibility than the small silica microspheres. At high concentration, only the small silica microspheres had a beneficial influence on the drug dispersibility. The results reveal influences of fine excipient materials on mixing mechanics. At low concentration, the fine particles improved deaggregation and distribution of the drug particles over the surfaces of the carrier particles. The large silica microspheres were associated with a greater mixing energy and a greater improvement in the drug dispersibility than the small silica microspheres. At high concentration, the large silica microspheres kneaded the drug particles onto the surfaces of the carrier particles and thus impaired the drug dispersibility. As a critical attribute of fine excipient materials in carrier-based dry powder inhalation formulations, the particle size demands robust specification setting.
尽管尚未完全了解,但优良辅料对基于载体的干粉吸入剂(DPI)制剂中药物分散性的贡献已得到充分认可。为了更好地理解这些贡献,我们研究了优良辅料的粒径对基于载体的DPI制剂特性的影响。我们研究了两种粒径等级的二氧化硅微球,体积中值直径分别为3.31μm和8.14μm,作为优良辅料。制备了吸入制剂,每种制剂均由乳糖载体材料、一种优良辅料(2.5%或15.0%/)和药物(丙酸氟替卡松)材料(1.5%/)组成。研究了制剂的物理微观结构、流变学性质、雾化模式和空气动力学性能。在低浓度下,大的二氧化硅微球对药物分散性的影响比小的二氧化硅微球更有利。在高浓度下,只有小的二氧化硅微球对药物分散性有有利影响。结果揭示了优良辅料对混合机制的影响。在低浓度下,细颗粒改善了药物颗粒在载体颗粒表面的解聚和分布。与小的二氧化硅微球相比,大的二氧化硅微球具有更大的混合能量和对药物分散性的更大改善。在高浓度下,大的二氧化硅微球将药物颗粒揉捏到载体颗粒表面,从而损害了药物分散性。作为基于载体的干粉吸入剂制剂中优良辅料的一个关键属性,粒径需要严格设定规格。